O'Shaughnessy Asset Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

O'Shaughnessy Asset Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41	Closed	-$1K	–	2704
2021 Q3	$1K	Buy	+41	New	+$733	﹤0.01%	2681
2018 Q4	–	Sell	-3,343	Closed	-$60K	–	1045
2018 Q3	$60K	Sell	3,343 -1,086	-25%	-$18.8K	﹤0.01%	702
2018 Q2	$63K	Sell	4,429 -983	-18%	-$17.3K	﹤0.01%	695
2018 Q1	$104K	Sell	5,412 -1,820	-25%	-$39.3K	﹤0.01%	621
2017 Q4	$166K	Buy	7,232 +5,133	+245%	+$164K	﹤0.01%	579
2017 Q3	$77K	Buy	+2,099	New	+$78.3K	﹤0.01%	664

Other funds holding OPNT

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

O'Shaughnessy Asset Management's OPNT Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2021, closing a stake of 41 shares — an estimated $1K sold.

O'Shaughnessy Asset Management first reported a position in OPNT in Q3 2017 and held it in 6 quarters. The position peaked at $166K in Q4 2017. 42 funds tracked by Wall St. Rank hold OPNT as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 41 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $1K.
O'Shaughnessy Asset Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
O'Shaughnessy Asset Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $166K in Q4 2017.
42 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.